Outset Medical (OM) Total Non-Current Liabilities (2019 - 2025)
Outset Medical (OM) reported Total Non-Current Liabilities of $137.5 million for Q4 2025, down 44.15% year-over-year from $246.3 million in Q4 2024, and up 1.97% on a QoQ basis from $134.9 million in Q3 2025.
Outset Medical (OM) has 7 years of Total Non-Current Liabilities data on file, last reported at $137.5 million in Q4 2025.
- Quarterly Total Non-Current Liabilities fell 44.15% year-over-year to $137.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $137.5 million (down 44.15% YoY) and the FY2025 annual result came in at $137.5 million, down 44.15% from the prior year.
- Total Non-Current Liabilities grew to $137.5 million in Q4 2025 per OM's latest filing, from $134.9 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $251.7 million in Q1 2024 and bottomed at $72.8 million in Q1 2021.
- The 5-year median for Total Non-Current Liabilities is $136.2 million (2025), against an average of $144.7 million.
- The widest annual swing landed in 2023, when Total Non-Current Liabilities jumped 80.98%; it then plunged 47.82% in 2025.
- Tracing OM's Total Non-Current Liabilities over 5 years: stood at $88.7 million in 2021, then soared by 73.71% to $154.0 million in 2022, then grew by 23.38% to $190.0 million in 2023, then grew by 29.61% to $246.3 million in 2024, then plunged by 44.15% to $137.5 million in 2025.
- Per Business Quant, the three latest OM Total Non-Current Liabilities figures stand at $137.5 million (Q4 2025), $134.9 million (Q3 2025), and $134.0 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Outset Medical | 90,946.35 | -286.55 Mn | 12.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 137.54 Mn |
| Sep 30, 2025 | 134.89 Mn |
| Jun 30, 2025 | 134.02 Mn |
| Mar 31, 2025 | 131.34 Mn |
| Dec 31, 2024 | 246.28 Mn |
| Sep 30, 2024 | 242.85 Mn |
| Jun 30, 2024 | 244.17 Mn |
| Mar 31, 2024 | 251.72 Mn |
| Dec 31, 2023 | 190.02 Mn |
| Sep 30, 2023 | 154.81 Mn |
| Jun 30, 2023 | 150.85 Mn |
| Mar 31, 2023 | 146.08 Mn |
| Dec 31, 2022 | 154.01 Mn |
| Sep 30, 2022 | 85.54 Mn |
| Jun 30, 2022 | 90.51 Mn |
| Mar 31, 2022 | 85.45 Mn |
| Dec 31, 2021 | 88.66 Mn |
| Sep 30, 2021 | 78.45 Mn |
| Jun 30, 2021 | 73.17 Mn |
| Mar 31, 2021 | 72.83 Mn |
| Dec 31, 2020 | 74.98 Mn |
| Sep 30, 2020 | 71.57 Mn |
| Dec 31, 2019 | 50.89 Mn |